Mamedica is a start-up which was founded in 2021 and launched in 2022. We are one of just four clinics in the U.K. to have obtained licensing to prescribe and dispense medical cannabis (offering cannabis flower to oil.) Our clinic provides virtual consultations to patients who suffer from pain, psychiatry, neurology, palliative care and cancer-related conditions.
Our team of specialist doctors provide expert initial evaluation and aftercare support to make sure our service is stress-free, simple, safe, and effective. Medication is then delivered to patients via secure courier.
听
听
听
How did you come up with the idea for the company?
听
I first became aware of cannabis around 20 years ago however, it wasn鈥檛 until I spent time in California that I realised the potential it had to improve the lives of people who were on much stronger medications. It was a more personal experience which proved to be the catalyst for Mamedica.
In May last year, a good friend of mine alluded to the fact he was suffering from anxiety and depression for which he had obtained a private medical cannabis prescription, but the service he was receiving wasn鈥檛 as good as he would have liked. As soon as I heard that, I instantly got to work trying to understand the patient experience, and how it could be improved.
听
More from Interviews
- Dear Mr. Prime Minister: Michaela Eschbach, CEO At Cambridge Wireless
- A Chat With Subomi Oluwalana, Founder And CEO Of Convoy And US50 2026 Judge
- Dear Mr. Prime Minister: Anne Cantelo, Founder Of Onyx Media And Communications
- A Conversation With Siphesihle Yokwe, Social Media And Paid Media Specialist And Founder Of Mvelo Mediahouse
- A Chat With Tshimologo Leburu, Founder And CEO At Virtual Africa On How African Freelancers Can Build Marketing Strategies for Global Businesses
- Meet Artem Kirillov: General Manager At Performa
- Interview With Alex Marshall, Group Director At Clarke Energy, A Rehlko Company On The Data Centre Industry
- Meet Oliver Yonchev: Co-Founder Of Potentially AI
How has the company evolved over the last couple of years/months?
听
We welcomed our first patients in June this year which was a significant milestone. We鈥檝e assembled a team made up of a diverse and passionate mix of specialist doctors, pharmacists and patient care coordinators focused on offering the best of what medical cannabis has to offer.
The journey from conception of idea, seeking the necessary regulatory approvals, to launching, has taken just over a year. In that time, we have secured 拢1 million in funding from private investors through Government incentive schemes (SEIS/EIS) and have successfully obtained licences from the Care Quality Commission and General Pharmaceutical Council to provide our services.
听
What can we hope to see from Mamedica in the future?
听
Most people are completely unaware that a service like ours exists. We鈥檙e here to provide education and insight into how medical cannabis can support patients across a number of conditions. Despite it becoming a legal pathway since 2018 we鈥檝e got a long way to go in the U.K. in terms of spreading awareness on how to access medical cannabis.
Our focus for Mamedica is to become a leading healthcare provider. We want patients, caregivers, medical professionals and loved ones to know our service is a legitimate and accessible pathway to improving lives.
